Friday March 22, 2019

Practo joins hands with Uber to bring more relief to patients

0
//
Picture Courtesy:-www.bgr.in

Hyderabad: Practo, Asia’s largest healthcare booking platform, and Uber, the world’s leading ride-hailing technology platform, have announced today a global partnership that will make it easier and quicker for consumers to reach doctors.

Starting Monday, Practo users across India, Indonesia, Philippines and Singapore who book an appointment on Practo’s app will be able to see the closest Uber available when they get a reminder alert for their appointments, said a statement.

Users can then click the reminder notification and complete the booking process.

New users who book their first appointment on the Practo app can avail two free rides, up to Rs.200 per ride, with Uber. This offer is valid till December 31.

The partnership also comes with an inaugural offer specific to India, where any existing or new user booking an appointment on Practo till November 30 gets a free ride to and from the doctor’s clinic.

We realised that transportation issues often bring additional stress to a doctor’s visit — having to drive through traffic, then hunt for parking — all while you or your loved one is sitting in the car feeling ill is a terrible experience.

 

“There are also many patients who may not be able to drive themselves to a doctor at all. Our goal with this partnership is to completely remove this anxiety by integrating with Uber’s incredible experience and bringing that to our consumers,” said Practo founder and CEO N.D. Shashank.

Uber India president Amit Jain said: “The technology integration through this partnership reflects our common commitment to create seamless experience for all our user.”

(Inputs from IANS)

Next Story

New Medicine That Could Replace Insulin Injections

The tip of the needle is made of nearly 100 per cent compressed, freeze-dried insulin. 

0
diabities
The tip of the needle is made of nearly 100 per cent compressed, freeze-dried insulin. Pixabay

Researchers have developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing injections for patients with Type-2 diabetes, says a new study.

About the size of a blueberry, the capsule contains a single and small needle made of compressed insulin, which is injected after the capsule reaches the stomach.

The study showed that the capsule could deliver enough insulin to lower blood sugar to levels comparable to those produced by injections given through skin. They also demonstrated that the device can be adapted to deliver other protein drugs.

diabities
About the size of a blueberry, the capsule contains a single and small needle made of compressed insulin, which is injected after the capsule reaches the stomach. VOA

“We are really hopeful that this new type of capsule could someday help diabetic patients and perhaps anyone who requires therapies that can now only be given by injection or infusion,” said Robert Langer, Professor at the Koch Institute for Integrative Cancer Research in Britain.

The tip of the needle is made of nearly 100 per cent compressed, freeze-dried insulin.

When the capsule is swallowed, water in the stomach dissolves the sugar disk, releasing the spring and injecting the needle into the stomach wall.

The stomach wall has no pain receptors, so the patients would not be able to feel the prick of the injection. To ensure that the drug is injected into the stomach wall, the researchers designed their system so that no matter how the capsule lands in the stomach, it can orient itself so the needle is in contact with the lining of the stomach.

The findings, published in the journal Science, showed that the researchers could successfully deliver up to 300 micrograms of insulin.

insulin
The type of drug delivery could be useful for any protein drug that normally has to be injected, such as immunosuppressants used to treat rheumatoid arthritis or inflammatory bowel disease and may also work for nucleic acids such as DNA and RNA, according to the researchers. Pixabay

More recently, they have been able to increase the dose to 5 milligrams, which is comparable to the amount that a patient with Type-2 diabetes would need to inject.

Also Read: A New Hope for Acute Liver Failure Patients

Furthermore, no adverse effects from the capsule was found, which is made from biodegradable polymer and stainless steel components.

Importantly, this type of drug delivery could be useful for any protein drug that normally has to be injected, such as immunosuppressants used to treat rheumatoid arthritis or inflammatory bowel disease and may also work for nucleic acids such as DNA and RNA, according to the researchers. (IANS)